Analystreport

Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "conviction-buy" rating.

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html